BRAF-mutated CRC: testing to treatment
Experts Prof. Sebastian Stintzing and Dr Thomas Winder discuss the significance of BRAF mutations in colorectal cancer (CRC), and the testing strategies and available treatments for these patients. ...
8 Nov 202425min
Neuroendocrine tumours (NETs) – Shared decision-making. Part 2: Individualising treatment decisions
In this second episode of a two-part podcast series focusing on neuroendocrine tumours (NETs), gastroenterologist Dr Mohid S Khan and NET patient Sally Jenkins explore shared decision-making, between ...
11 Sep 202422min
Neuroendocrine tumours (NETs) – Shared decision-making. Part 1: Patient journey
In this first episode of a two-part podcast series focusing on neuroendocrine tumours (NETs), gastroenterologist Dr Mohid S Khan and NET patient Sally Jenkins discuss the importance of communication a...
11 Sep 202429min
Regional differences in NET: Treatment and future developments
In the second episode of a two-part podcast series, Prof. Martyn Caplin and Prof. Rachel Riechelmann discuss how to optimize treatment for people living with NETs and future developments in the field ...
28 Mai 202421min
Regional differences in NET: Epidemiology, diagnosis, and referral strategies
In this first episode of a two-part podcast series, Prof. Martyn Caplin and Prof. Rachel Riechelmann discuss regional differences in NET epidemiology, and patient pathways, as well as look to future d...
28 Mai 202421min
Understanding the needs of different patient populations in colorectal cancer
Do you understand the needs of different patient groups with colorectal cancer? Do you know about the barriers to treatment experienced by different ethnicities, socioeconomic groups and younger pati...
15 Mai 202425min
Interpreting real-world evidence in later-line mCRC
What are the challenges and considerations when using real-world evidence to inform your clinical practice? How can data from real-world studies be used to complement data from clinical trials? In ...
7 Mai 202427min
Cáncer de ovario: dificultades en la fase preanalítica y pruebas de biomarcadores
¿Cuáles son los desafíos frecuentes en la fase preanalítica del cáncer de ovario, y cómo podemos solucionarlos? ¿Por qué es importante identificar las alteraciones genéticas? Usted está viendo el te...
25 Apr 202432min
